Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

Acquisitions (Tables)

3 Months Ended

Sep. 30, 2014

Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed Pending Final Valuation of Intangible Assets

The preliminary estimated fair value of the assets acquired and liabilities assumed in each acquisition, pending final valuation of intangible assets, was as follows (in thousands):


	Novus		ProteinSimple
Current assets	$	10,739	$	20,321
Equipment		1,266		1,983
Other long-term assets		40		554
Intangible Assets:
Developed technology		5,110		41,200
Trade name		5,800		36,300
Customer relationships		16,100		101,100
Non-compete agreements		0		200
Goodwill		23,233		132,967

Total assets acquired		62,288		334,625
Liabilities		2,166		11,304
Deferred income taxes, net		0		23,268

Net assets acquired	$	60,122	$	300,053

Cash paid, net of cash acquired	$	60,122	$	300,053